Literature DB >> 16286799

Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy.

Masahiko Sugimoto1, Mikio Sasoh, Masashi Ido, Yoshikatsu Wakitani, Chisato Takahashi, Yukitaka Uji.   

Abstract

PURPOSE: To detect early diabetic damage in type 2 diabetes mellitus patients with no diabetic retinopathy (NDR) using optical coherence tomography (OCT) and to evaluate OCT as a clinical test.
METHODS: Thirty-two patients with NDR (n = 32) were enrolled. We examined retinal and retinal nerve fiber layer (RNFL) thickness using OCT. Two healthy normal populations were also enrolled for the retinal thickness (n = 48) and RNFL thickness (n = 34). Both OCT measurements were obtained in four areas (temporal, superior, nasal and inferior). The receiver operator characteristic (ROC) curve was generated to evaluate the predictor variables.
RESULTS: Comparing the normal and NDR eyes, retinal thickness significantly increased (p = 0.03) and RNFL thickness significantly decreased (p = 0.02) in the superior areas. The area under the ROC curve was 0.65 for the superior retinal thickness and 0.63 for the superior RNFL thickness.
CONCLUSIONS: Both OCT measurements can detect early retinal damage in NDR patients. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 16286799     DOI: 10.1159/000088382

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  48 in total

1.  Structural neurodegeneration correlates with early diabetic retinopathy.

Authors:  Ulrik Frydkjaer-Olsen; Rasmus Soegaard Hansen; Tunde Peto; Jakob Grauslund
Journal:  Int Ophthalmol       Date:  2017-07-21       Impact factor: 2.031

2.  Aldose reductase inhibition alleviates hyperglycemic effects on human retinal pigment epithelial cells.

Authors:  Kun-Che Chang; Anson Snow; Daniel V LaBarbera; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2014-10-18       Impact factor: 5.192

3.  Influence of diabetes on macular thickness measured using optical coherence tomography: the Singapore Indian Eye Study.

Authors:  C C A Sng; C Y Cheung; R E Man; W Wong; R Lavanya; P Mitchell; T Aung; T Y Wong
Journal:  Eye (Lond)       Date:  2012-02-17       Impact factor: 3.775

4.  Optic disc topographic analysis in diabetic patients.

Authors:  Ibrahim Toprak; Cem Yildirim; Volkan Yaylali
Journal:  Int Ophthalmol       Date:  2012-07-24       Impact factor: 2.031

5.  Global flash multifocal electroretinogram: early detection of local functional changes and its correlations with optical coherence tomography and visual field tests in diabetic eyes.

Authors:  J C Y Lung; P G Swann; D S H Wong; H H L Chan
Journal:  Doc Ophthalmol       Date:  2012-07-25       Impact factor: 2.379

6.  Glial and neuronal dysfunction in streptozotocin-induced diabetic rats.

Authors:  Vickie H Y Wong; Algis J Vingrys; Bang V Bui
Journal:  J Ocul Biol Dis Infor       Date:  2011-12-31

7.  A test of a linear model of glaucomatous structure-function loss reveals sources of variability in retinal nerve fiber and visual field measurements.

Authors:  Donald C Hood; Susan C Anderson; Michael Wall; Ali S Raza; Randy H Kardon
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

8.  Retinal Nerve Fiber Layer Decrease during Glycemic Control in Type 2 Diabetes.

Authors:  Masahiko Sugimoto; Mikio Sasoh; Masashi Ido; Chisato Narushima; Yukitaka Uji
Journal:  J Ophthalmol       Date:  2010-08-08       Impact factor: 1.909

9.  Endoplasmic reticulum stress and inflammation: mechanisms and implications in diabetic retinopathy.

Authors:  Sarah X Zhang; Emily Sanders; Joshua J Wang
Journal:  J Ocul Biol Dis Infor       Date:  2012-01-18

10.  Adolescents with Type 2 diabetes: early indications of focal retinal neuropathy, retinal thinning, and venular dilation.

Authors:  Kevin W Bronson-Castain; Marcus A Bearse; Jessica Neuville; Soffia Jonasdottir; Barbara King-Hooper; Shirin Barez; Marilyn E Schneck; Anthony J Adams
Journal:  Retina       Date:  2009-05       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.